You have 7 free searches left this month | for more free features.

HCV GT4

Showing 26 - 50 of 4,415

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Chronic HCV Infection Trial in China (HEC74647PA+HEC110114, Placebo)

Recruiting
  • Chronic HCV Infection
  • Bengbu, Anhui, China
  • +35 more
May 24, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Thyroid Function After Cardiopulmonary Resuscitation

Recruiting
  • Heart Arrest
  • +3 more
  • TSH determination
  • +4 more
  • Bochum, NRW, Germany
    Medizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-
Aug 13, 2021

Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)

Active, not recruiting
  • Aortic Valve Disease
  • Aortic Valve Disorder
  • Trifecta GT (Glide Technology) Valve
  • Rochester, Minnesota
  • +26 more
Mar 10, 2022

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Kidney Failure, Hepatitis C, Kidney Disease, Chronic Trial in Boston (Glecaprevir and Pibrentasvir)

Recruiting
  • Kidney Failure
  • +2 more
  • Glecaprevir and Pibrentasvir
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 4, 2021

Hematologic and Lymphocytic Disorder Trial in Houston (Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan,

Recruiting
  • Hematologic and Lymphocytic Disorder
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

Completed
  • Hepatitis C Virus (HCV)
  • Glecaprevir/pibrentasvir adult formulation
  • Glecaprevir/pibrentasvir pediatric formulation
  • San Francisco, California
  • +37 more
Sep 19, 2022

Obesity Trial in Worldwide (Side-to-side anastomosis duodeno-ileostomy diversion procedure)

Recruiting
  • Obesity
  • Side-to-side anastomosis duodeno-ileostomy diversion procedure
  • Brussels, Belgium
  • +4 more
Apr 4, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

HCV Infection Trial in Hong Kong (SOF+DCV+CDI-31244, SOF+DCV+CDI-31244+ASV)

Withdrawn
  • HCV Infection
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
May 5, 2020

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX

Recruiting
  • Hepatitis C
    • Istanbul, Turkey
      Cerrahpasa Medical Faculty
    Aug 26, 2023

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)

    Recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 21, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +14 more
    • Aldesleukin
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))

    Recruiting
    • Hepatitis C Virus (HCV)
    • Glecaprevir/Pibrentasvir (GLE/PIB)
    • Chandler, Arizona
    • +62 more
    Aug 8, 2022

    Recurrent DLBCL, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Houston (drug, procedure, other, biological)

    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)

    Completed
    • Chronic Hepatitis C Virus
    • Hepatitis C Virus
    • (no location specified)
    Jul 14, 2021

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

    Completed
    • Hepatitis C Virus (HCV)
    • San Diego, California
    • +24 more
    Jul 14, 2021